Overview

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Status:
Completed
Trial end date:
2019-03-15
Target enrollment:
Participant gender:
Summary
A study to evaluate the efficacy and safety of dasotraline in children 6 to 12 years of age with Attention-Deficit Hyperactivity Disorder (ADHD) in a simulated classroom setting.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion